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CONCLUSION
There would now appear to be no place in the treatment of
obesity for amphetamines and derivatives which possess
stimulating properties. Because of their euphoriant effect
they are potentially dangerous drugs." The BMA Working
Party conclusion was: 'Amphetamine drugs should be
avoided as far as possible in the treatment of obesity but
if in individual cases the doctor feels they must be em-
ployed, they should be prescribed for a limited period
only. Of the compounds avaiJable, fenfluramine seems to
have the least undesirable side-effects.'
Fulton in Prescribers' ]ollrnaf' also stated: 'Ampheta-
mines and related compounds depress appetite (in addition
to their placebo action) but they tend to lose this effect in
about two months; the majority produce dependence. The
use of amphetamines or a similar drug ... in an attempt
to assist weight reduction is a short-sighted policy. The
practice should cease. Fenfluramine (Ponderax) has an
anorectic effect which lasts about twice as long as the
amphetamines. It is not, like them, a eNS stimulant and
is not subject to the provisions of the Drugs (Prevention
of M isuse) Act, 1964, as are all the other preparations
listed above.'
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TWO soum WEST AFRICAN CASES OF BURKIIT LYMPHOMA*
S. S. GROvE, M.D., ER.C.S. (ENG.), South African Institute for Medical Research, AND G. VAN BILJON, B.Sc., M.B.,
CH.B. (STELL.), State Native Hospital, Windhoek, SWA
SUMMARY
Two cases from South West Africa presenting with intra-
abdominal Burkitt tlImours are described. One patient, after
an initial dramatic response to vincristine sulphate therapy,
relapsed and died, apparently insensitive to further chemo-
therapy. The second patient died before the histological
d:agnosis became known. These are, as far as is known,
the first cases from South WeSi Africa to be described.
The climatic and geographical conditions of the territory
of SO/ah West Africa are discussed in view 'of the
differences as compared with those of countries in which
*Date received: 22 December 1970.
BlIrkitl's tumour occurs as a common malignancy in
childhood.
The African lymphoma syndrome has featured promi-
nently in the literature since attention was drawn to a
number of unusual features surrounding the disease.'"
From the numerous observations and studies on the so-
called Burkitt lymphoma, those of the high cure rate by
means of, chemotherapy"s and those of the roles played
by epidemiological,'" immunological'· and viral agents in
the aetiology of the disease" have probably been the most
fascinating. New hope and interest have been stimulated in
cancer research following these findings.
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CASE REPORTS
Fig. 1. Localities in South West Africa from where the
two cases of Burkitt lymphoma came.
indicate any abnormalities of the genito-urinary sY5tem.
A laparotomy carried out soon after admission to
hospital showed extensive neoplastic masses, most of
which involved the mesentery of the small intestine. A large
mesenteric growth which infiltrated the ileum was resected,
but removal of further growth deposits in the pelvic and
abdominal cavities was not attempted (Fig. 2). Histological
examination of the resected tumour showed the well-
known features of Burkitt's African lymphoma of the
poorly differentiated lymphocytic type (Fig. 3).
Fig. 3. Section of the tumour in Case in which a typical
'starry-sky' appearance was seen.
~"~;PI!l.~!llrllllt'~'lII:~l'l~t!'illllIW:!lllllr~III~"PI'tllll!)'~[!I'II~£2~:li~~~!:I'
Fig. 2. The laparotomy specimen of the tumour in Case I.
Intravenous injections of vincristine sulphate in I-mg
doses weekly were instituted. This treatment caused the
extensive intra-abdominal tumour to disappear dramati-
cally within a period of 4 - 5 days. Following on the
satisfactory response to the drug, the general condition of
the patient improved. She developed an appetite and was
able to get out of bed for the first time since admission.
However, some 3 weeks later, while still receiving weekly
injections of vincristine sulphate, the abdominal tumour
masses reappeared rapidly. Methotrexate therapy was
started but her condition deteriorated rapidly, and the











The occurrence of 2 cases with the syndrome in South
West Africa within a period of 6 months is reported
because of the exceptional geographic and climatic condi-
tions prevailing in this territory compared with that of
other countries where this malignant d;sease is common
in childhood.
Two cases of Burkitt's tumour syndrome from South
West Africa were recently seen. One patient came from
the Kamanjab district in South West Africa while the other
developed the lymphoma in the Kavango territory. (Fig. I).
Case 1
A lO-year-old Bantu girl was admitted to hospital in
Windhoek from the north-western area of South West
Africa with symptoms of vomiting, diarrhoea and ab-
dominal pain for 14 days. The parents had not~ced con-
siderable weight loss and abdominal distension for pro-
bably one month before admission. The patient had lived
all her life in the Kamanjab area where her father worked
as a farm labourer. On admission to hospital, she was
found to be a frail-looking girl in whom there was obvious
marked weight loss and considerable abdominal distension.
On examination it was found that the distension of the
abdomen was due partly to ascites and partly due to large
firm irregular abdominal masses. Peripheral lymphadeno-
pathy was absent.
A full blood count showed a haemoglobin level of
9'1 g /100 m!. The white cell count was 8 000/ mm' and the
differential count was within normal limits. Features
suggestive of a leukaemia were not observed at any time
during regular haematological investigations.
Radiography of the skeleton did not at any time show
evidence of bony metastases.
Intravenous pyelography on different occasions did not
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therapeutic drugs. The disease from the time of its re-
currence progress~d relentlessly to a rapid fatal termina-
tion.
A postmortem examination showed intra-abdominal
tumours involving the mesentery, intestines, retroperitoneal
tissues and pelvic organs. The growth had caused matting
of intra-abdominal lymph nodes and organs, making it
impossible to determine a primary site of the growth with
any precision. The kidneys, spleen, liver, suprarenals and
pancreas did not show tumour deposits. There was no
evidence of any bony metastases or of peripheral or intra-
thoracic lymph-node involvement.
Case 2
A small Bantu boy aged 5 years was admitted to
hospital at Rundu in the Kavango territory where he was
treated for urinary schistosomiasis. Shortly before he was
due for discharge from hospital, a mass, which had
apparently developed rapidly, became palpable in the
abdomen. Peripheral lymph nodes were clinically of normal
size and consistency. .
At laparotomy growths in the small intestinal mesentery
infiltrating the ileum were found. These tumours had
apparently developed in mesenteric lymph nodes and had
progressed to partial obstruction of the wall of the ileum.
After the operation the patient's general condition deterior-
ated unexpectedly and he died a few days later. The
laparotomy specimen (Fig. 4) showed histological features
of a lymphoma belonging to the same group of poorly




Fig. 4. Naked-eye view of the mesenteric tumour mass
infiltrating the ileal wall in Case 2.
Radiographic investigations for skeletal or renal meta-
stases were not carried out as the histopathological report
on the operation specimen was received only after death.
Full blood counts carried out before the operation did not
show any abnormality of the peripheral blood.
CLIMATIC AND PARASITOLOGICAL DATA OF SWA
The annual rainfall over most of South West Africa is
sparse. The Kamanjab area, whence patient No. 1- was
sent, lies at an altitude of I 300 m above sea-level and has
an average annual rainfall of probably Dot more than
Fig. 5. Section of the growth in the intestine showing an
undifferentiated lymphosarcoma; the 'starry-sky' pattern
was less marked in the second case.
300 mm. The Okavango river region, of which patient
No. 2 was a native, has, with more than 600 mm per
annum, the highest rainfall in South West Africa. The
Kavango is a thickly-wooded country lying at an altitude
of approximately I 000 m above sea-level. Malaria is
hyperendemic in the Okavango River region," but only
sporadic cases occur annually in the Kamanjab district.
Vigorous malarial control measures are in constant opera-
tion in the Kavango territory where the population live
for the most part, because of fishing, along the banks of
the Okavango River. The river which forms the border
between South West Africa and Angola is infested with
bilharzia, and a very large section of the population
suffers from the disease.
DISCUSSION
Two cases which fall clinically and histopathologically into
the group of lymphosarcomas referred to as Burkitt's
African lymphoma occurred in South West Africa within
6 months of each other. To our knowledge the occurrence
of this form of lymphosarcoma has not been previously
recognized in South West Africa. It seems feasible, how-
ever, that as the medical services in the territory are
extended and as transport facilities improve, further cases
may be expected in future. Cases of the Burkitt type of
lymphoma have been described from Portuguese East
Africa l3 and from various centres in the Republic of South
Africa."-lT
Recently a 3-year-old child, domiciled in Sa da Bandeira
in Angola and of white Portuguese parentage, was referred
to Windhoek, suffering from a typical facial type of
Burkitt lymphoma. A biopsy specimen of the tumour
eX<lmined histologically confirmed this clinical diagnosis
but the child returned to Angola before adequate treat-
ment was given and has since been reported to have died
of the disease. While in Windhoek, peripheral lymphadeno-
pathy was at no time observed.
The incidence of the so-called African lymphoma in
South West Africa could probably be regarded as 'occa-
sional' or 'rare'.' Certain sections of the Okavango River
with its swamps and the Caprivi Zipfel may well prove,
on climatic, geographical, epidemiological and entomolo-
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gical grounds, to have a higher incidence of the African
lymphoma syndrome than elsewhere in South West Africa
or the Republic of South Africa. The Okavango River
area, along which the entire Bantu population of Kavanoo-
land is concentrated, is a mosquito-infested country. For
mainly geographical reasons the intensive malarial control
measures in the Kavango probably do not produce the
same striking success as in other parts of the territory.
Bilharzia infestation with both S. haemarobiuJn and S.
mansoni in different localities is present in a varying but
always very high percentage of the Kavango people.
Sporadic cases of trypanosomiasis occur along the western
Caprivi, but all have occurred in members of nomad tribes
who probably acquired the disease in countries to the
north of the South West African border.
There seems to be considerable evidence that the Burkitt
type of poorly different:ated lymphosarcoma in children
described from some parts of Africa, merits its being
placed into a special category for several reasons. The
commonest clinical presentation of the growth is in the
maxilla and/ or mandible or intra-abdominally.""'" Peri-
pheral lymphadenopathy and leukaemic changes are
notably absent in patients with the Burkitt lymphoma.''''''
The Burkitt lymphoma, which is the commonest malignant
tumour of children in some parts of Africa, exhibits rapid
growth and responds to chemotherapeutic treatment result-
ing in what is for lymphomas a high and unique percentage
of cures.""
An association with the epidemicity of malaria and with
the immunological response evoked by malarial infesta-
tion further serves to emphasize the individuality of the
Burkitt tumour in the lymphoma group of cancers. Morbid
anatomical findings indicate a pattern of development of
the disease in children which is different from that of the
classical lymphosarcoma at this age. The World Health
Organization's memorandum on the histopathological
definition of Burkitt's tumour concludes, among other
things: 'the eponym Burkitt's tumour is best applied to a
malignant neoplasm of the haemopoietic system composed
of a predominant and characteristic cell type'. The same
memorandum emphasizes, however, that the prominent
so-called 'starry-sky' feature seen histologically is not
specific or pathognomonic of Burkitt's tumour." :it could
be argued, therefore, with some justification, that the
Burkitt lymphoma merits consideration as a separate
independent tumour entity within the lymphosarcoma sub-
division of malignant lymphomas. Burkitt's tumour is seen,
notwithstanding its special features, also in other parts of
the world besides Africa and it cannot be denied that
certain histopathological features of Burkitt's tumour may
be found in lymphomas of other types as well.
Both the Bantu cases reported showed intra-abdominal
tumour masses. Case I did not show any bony lesions
and diffuse tumour growth in the abdominal and pelvic
cavities would have obscured any primary site of the
growth had it been present. An autopsy was not carried
out in case 2 because the patient died at Rundu before
the histological findings were known. Both cases fitted into
the group presenting with abdominal tumours and reported
to comprise 40% of all cases with the disease in Africa.
In hyperendemic or holo-endemic malarial areas strict
preventive control measures of the vector mosquitoes
could result in a diminution of the incidence· of Burkitt
lymphoma. It has not, as far as can be judged, been
established whether other chronic parasitic disease processes
play a role in the aetiology of the disease in the same way
as malaria seems to do. Could chronic bilharzia be of
importance in some areas of Africa as regards an altered
immunological response to a virus causing lymphoma?
Does an immunological reaction to the mosquito toxins
of repeated bites over a long period change the response
to a known viral agent so that Burkitt tumours result? It
may well be that we are not dealing, as is thought, with a
new malignant disease but that there are other aetiological
routes along which it may be acquired and that only the
expression of the disease differs, i.e. a change of the who,
where, why and how of the illness. It could be that, if
the Epstein-Barr virus is responsible,'o,1l a shortcut opens
up for a malignant transformation of cells by simul-
taneously operating immunological factors. Other less
potent and as yet undiscovered factors in other communities
of the world may operate to produce lymphosarcomas as
a result of an infection by the same, or other, virus. All
histopathologists of experience have at some time examined
a lymph node of suspected glandular fever cases with some
misgiving about the benignity of the condition. Many of
us have been worried by the marked atypicality of the
glandular fever cells in peripheral blood smears of such
patients and have remembered Damashek's remarks with
some uneasiness of mind.
Whatever the final word on the Burkitt lymphoma may
be, no one can deny the importance of the outstanding
work which has been done in many parts of Africa, which
leaves one, when reviewing the extensive literature, with
the impression that important progress has been made in
the solution of some of our cancer problems.
We wish to thank the Directors of the South African Institute
for Medical Research and the South West African Admini-
stration, for facilities to carry out this study.
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